Overhauling clinical trials

Article Abstract:

The European Medicines Agency (EMEA) and the U.S. Food and Drug Administration (FDA) have issued guidelines on the new types of clinical trial techniques that are referred to as flexible or adaptive. The advantages and limitations of these adaptive clinical trials are discussed and compared with the randomized controlled trials, which are used for more than half a century.

Europe, Legal issues & crime, Government regulation (cont), Government regulation, Management dynamics, Legal/Government Regulation, Methods, Management, Laws, regulations and rules, Clinical trials, Company business management, United States. Food and Drug Administration, European Agency for the Evaluation of Medicinal Products

---

Better living through microbes

Article Abstract:

Streptococcus mutans is the species of the modified live bacteria that will replace their naturally occurring, acid-making counterparts, which lack the gene to make enamel-eroding lactic acid. Organics hopes that eventually the bacteria will become a routine part of dentistry, a one-time treatment applied to children's teeth before they start getting cavities.

Streptococcus mutans, Genetically modified organisms, Dental caries research

---

Anti-infective antibodies: Finding the path forward

Article Abstract:

Several pharmaceutical companies are investigating antimicrobial antibodies in their quest to find new weapons to fight infections. Increasing number of patients are dying from bacterial infections and therefore physicians are looking for better treatment and healthcare and the pharma companies are concentrating on antibiotic program.

Pharmaceutical Preparation Manufacturing, Antiinfective Preparations, Causes of, Anti-infective agents, Bacterial infections

Similar abstracts:

• Abstracts: Where have all the antibiotic patents gone? Fishing for cancer models
• Abstracts: China beckons to clinical trial sponsor. Chinese manufacturers vie for piece of outsourcing pie. China kickstart its vaccine market
• Abstracts: How to conduct competitive intelligence in your biotech startup. The role of competitive intelligence in biotech startups
• Abstracts: Domestic and foreign earnings, stock return variability, and the impact of investor sophistication. The association between outside directors, institutional investors and the properties of management earnings forecasts
• Abstracts: Official: FCS to be 'far more survivable' than current platforms. Analyst: FCS good news, bad news

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.